INCYTE CORP

13D and 13G Filings

13D/G filings
13G on 1 security
CIK
0000879169
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13G · 1 security · passive
Prelude Therapeutics, Inc. 13G
PRLD · 74065P101
9.9% 11/7/2025
Event 11/3/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.